Leveraging Genetic Testing in Lethal Congenital Contracture Syndrome 8
Explore how genetic testing aids in diagnosing Lethal Congenital Contracture Syndrome 8, informing family planning, and guiding personalized treatment strategies.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Lethal Congenital Contracture Syndrome 9: Unraveling the Genetic Threads
Explore the genetic basis of LCCS9, a rare disorder, with insights on genetic testing, carrier screening, and counseling for informed family planning and care.
Lethal Fetal Cerebrorenogenitourinary Agenesis/Hypoplasia Syndrome: A Genetic Insight into a Rare Disorder
Explore how genetic testing assists in early diagnosis and management of Lethal Fetal Cerebrorenogenitourinary Agenesis/Hypoplasia, a rare and severe genetic disorder.
Lifting the Veil on Lichtenstein-Knorr Syndrome: The Role of Genetic Testing
Explore the impact of genetic testing on Lichtenstein-Knorr Syndrome, focusing on accurate diagnosis, early detection, family planning, and research advancements.
Lipoyl Transferase 1 Deficiency: Unraveling the Genetic Code
Explore lipoyl transferase 1 deficiency, a rare mitochondrial disorder. Discover how genetic testing aids in diagnosis, treatment, and family planning.
Linking Genetic Testing to Lissencephaly 7 with Cerebellar Hypoplasia: A Pathway to Better Understanding
Unlock the potential of genetic testing for Lissencephaly 7 with cerebellar hypoplasia. Discover how early detection aids diagnosis, management, and personalized therapies.
Long QT Syndrome 14: Unveiling the Genetic Underpinnings of a Silent Threat
Genetic testing reveals key mutations in Long QT Syndrome 14, crucial for early intervention, personalized care, and preventing life-threatening heart arrhythmias.
Long QT Syndrome 15: Unlocking the Mysteries with Genetic Testing
Explore Long QT Syndrome 15, a rare heart disorder linked to KCNE1 mutations. Discover how genetic testing helps in early diagnosis, tailored treatment, and family planning.